10.8.2
To whom applies aDSM
National TB Management Guidelines, 2018 Edition. Chapter 10, Programmatic and Clinical Management of Drug-Resistant TB.
Clinical description
(i) TB patients treated with new medicines, such as bedaquiline or delamanid;
(ii) TB patients enrolled on treatment with novel regimens, such as the shorter MDR-TB treatment regimen;
(iii) All XDR-TB patients on second-line treatment (as these regimens often include multiple repurposed medicines)
Need this without data?
The app holds every guideline on your device, with calculators, bookmarks and notes.